🔎 Trials Near Me

Home › Kanser sa Ovary › Alaska

Pag-aaral pangklinika para sa Kanser sa Ovary sa Alaska

7 pag-aaral para sa Kanser sa Ovary ang naghahanap ng mga kalahok sa mga site sa Alaska.

Mga Lungsod sa Alaska

Opisyal na teksto ng pag-aaral (English)

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

  • Alaska Women's Cancer Care, Anchorage
Nagre-recruitPhase 2
Lahat ng edad · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT05564377

Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression

  • Alaska Womens Cancer Care Akwcc, Anchorage
Nagre-recruitPhase 3
Edad 18 pataas · Kababaihan · Na-update Set 15, 2026 · NCT07214779

A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer

  • Anchorage Associates in Radiation Medicine, Anchorage
  • Alaska Breast Care and Surgery LLC, Anchorage
  • Alaska Oncology and Hematology LLC, Anchorage
  • at 3 pa
Nagre-recruit
Edad 35 hanggang 50 · Kababaihan · Na-update Ago 7, 2026 · NCT04251052

Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

  • Anchorage Associates in Radiation Medicine, Anchorage
  • Alaska Breast Care and Surgery LLC, Anchorage
  • Alaska Oncology and Hematology LLC, Anchorage
  • at 4 pa
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 7, 2026 · NCT06580314

A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

  • Alaska Women's Cancer Care, Anchorage
Nagre-recruitPhase 2/3
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 28, 2026 · NCT06161025

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

  • Alaska Oncology and Hematology, Anchorage
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 6, 2026 · NCT04389632

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.